Literature DB >> 31291637

Adropin: Connection between Nonalcoholic Fatty Liver Disease and Coronary Artery Disease.

Mehmet Akif Erdol1, Seyma Ertem2, Ahmet Goktug Ertem3, Koray Demirtas1, Sefa Unal1, Mustafa Karanfil1, Ahmet Akdi1, Cagri Yayla1.   

Abstract

Entities:  

Year:  2019        PMID： 31291637      PMCID： PMC7024872          DOI： 10.1159/000502039

Source DB:  PubMed          Journal:  Med Princ Pract        ISSN： 1011-7571            Impact factor:   1.927


× No keyword cloud information.
  5 in total

1.  Adropin is a novel regulator of endothelial function.

Authors:  Fina Lovren; Yi Pan; Adrian Quan; Krishna K Singh; Praphulla C Shukla; Milan Gupta; Mohammed Al-Omran; Hwee Teoh; Subodh Verma
Journal:  Circulation       Date:  2010-09-14       Impact factor: 29.690

2.  Serum Adropin Levels Are Reduced in Adult Patients with Nonalcoholic Fatty Liver Disease.

Authors:  Orkide Kutlu; Özgür Altun; Okan Dikker; Şerife Aktaş; Neslihan Özsoy; Yücel Arman; Eylem Özgün Çil; Mustafa Özcan; Şengül Aydın Yoldemir; Murat Akarsu; İlkim Deniz Toprak; Kerem Kırna; Yasin Kutlu; Zeki Toprak; Hasan Eruzun; Tufan Tükek
Journal:  Med Princ Pract       Date:  2019-04-16       Impact factor: 1.927

3.  Serum adropin level in patients with stable coronary artery disease.

Authors:  Liang-Ping Zhao; Wei-Ting Xu; Li Wang; Tao You; Siew-Pang Chan; Xin Zhao; Xiang-Jun Yang
Journal:  Heart Lung Circ       Date:  2015-03-27       Impact factor: 2.975

4.  Identification of adropin as a secreted factor linking dietary macronutrient intake with energy homeostasis and lipid metabolism.

Authors:  K Ganesh Kumar; James L Trevaskis; Daniel D Lam; Gregory M Sutton; Robert A Koza; Vladimir N Chouljenko; Konstantin G Kousoulas; Pamela M Rogers; Robert A Kesterson; Marie Thearle; Anthony W Ferrante; Randall L Mynatt; Thomas P Burris; Jesse Z Dong; Heather A Halem; Michael D Culler; Lora K Heisler; Jacqueline M Stephens; Andrew A Butler
Journal:  Cell Metab       Date:  2008-12       Impact factor: 27.287

5.  Association between serum adropin level and burden of coronary artery disease in patients with non-ST elevation myocardial infarction.

Authors:  Ahmet Göktuğ Ertem; Sefa Ünal; Tolga Han Efe; Burak Açar; Çağrı Yayla; Mevlüt Serdar Kuyumcu; Özgür Kırbaş; Cemal Köseoğlu; Mehmet Kadri Akboğa; Kadriye Gayretli Yayla; Serkan Gökaslan; Sinan Aydoğdu
Journal:  Anatol J Cardiol       Date:  2016-09-28       Impact factor: 1.596
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.